Pernix Therapeutical Holdings Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Private

  • Employees
  • 147

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 13

  • Investments
  • 12

Pernix Therapeutical Holdings General Information

Description

Developer and marketer of specialty pharmaceutical products intended to expand access to clinically differentiated, underappreciated medicines as both branded and generic. The company focuses on the acquisition, development, and commercialization of prescription drugs and aims to underserved therapeutic areas, such as the central nervous system, including neurology, pain and psychiatry.

Contact Information

Formerly Known As
Pernix Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Corporate Office
  • 155 Franklin Road
  • Suite 450
  • Brentwood, TN 37027
  • United States
+1 (800)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 155 Franklin Road
  • Suite 450
  • Brentwood, TN 37027
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pernix Therapeutical Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pernix Therapeutical Holdings‘s full profile, request access.

Request a free trial

Pernix Therapeutical Holdings Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer and marketer of specialty pharmaceutical products intended to expand access to clinically differentiated, unde
Drug Discovery
Brentwood, TN
147 As of 2022

Basel, Switzerland
 

Mumbai, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pernix Therapeutical Holdings Competitors (42)

One of Pernix Therapeutical Holdings’s 42 competitors is Novartis, a Corporation company based in Basel, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novartis Corporation Basel, Switzerland
Cipla Corporation Mumbai, India
Landsteiner Scientific Formerly PE-Backed Toluca, Mexico
Astellas Pharma Corporation Tokyo, Japan
Chiesi Farmaceutici Private Debt Financed Parma, Italy
You’re viewing 5 of 42 competitors. Get the full list »

Pernix Therapeutical Holdings Patents

Pernix Therapeutical Holdings Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10150784-B2 Crystal polymorph of magnesium glycinate dihydrate and process for its preparation Inactive 30-Nov-2012
US-20140186408-A1 Crystal polymorph of magnesium glycinate dihydrate and process for its preparation Active 30-Nov-2012
US-20160326188-A1 Crystal polymorph of magnesium glycinate dihydrate and process for its preparation Active 30-Nov-2012
US-9394318-B2 Crystal polymorph of magnesium glycinate dihydrate and process for its preparation Inactive 30-Nov-2012
US-20110045063-A2 Phosphate-binding magnesium salts and uses thereof Active 10-Apr-2009 A61K33/06
To view Pernix Therapeutical Holdings’s complete patent history, request access »

Pernix Therapeutical Holdings Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pernix Therapeutical Holdings Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pernix Therapeutical Holdings‘s full profile, request access.

Request a free trial

Pernix Therapeutical Holdings Investments & Acquisitions (12)

Pernix Therapeutical Holdings’s most recent deal was a Merger/Acquisition with Nalpropion Pharmaceuticals. The deal was made on 27-Sep-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Nalpropion Pharmaceuticals 27-Sep-2019 Merger/Acquisition Pharmaceuticals
North American Right to ONZETRA XSAIL 26-Sep-2019 Corporate Asset Purchase Buildings and Property
Zogenix (Zohydro business) 24-Apr-2015 Merger/Acquisition Pharmaceuticals
GlaxoSmithKline (Treximet sumatriptan / naproxen sodium) 20-Aug-2014 Merger/Acquisition Drug Discovery
KHEDEZLA 27-Feb-2014 Corporate Asset Purchase Buildings and Property
You’re viewing 5 of 12 investments and acquisitions. Get the full list »

Pernix Therapeutical Holdings Exits (1)

Pernix Therapeutical Holdings’s most recent exit was on 02-Jul-2012 from Pernix Manufacturing. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Pernix Manufacturing 02-Jul-2012 Completed
To view Pernix Therapeutical Holdings’s complete exits history, request access »

Pernix Therapeutical Holdings FAQs

  • When was Pernix Therapeutical Holdings founded?

    Pernix Therapeutical Holdings was founded in 1996.

  • Where is Pernix Therapeutical Holdings headquartered?

    Pernix Therapeutical Holdings is headquartered in Brentwood, TN.

  • What is the size of Pernix Therapeutical Holdings?

    Pernix Therapeutical Holdings has 147 total employees.

  • What industry is Pernix Therapeutical Holdings in?

    Pernix Therapeutical Holdings’s primary industry is Drug Discovery.

  • Is Pernix Therapeutical Holdings a private or public company?

    Pernix Therapeutical Holdings is a Private company.

  • What is Pernix Therapeutical Holdings’s current revenue?

    The current revenue for Pernix Therapeutical Holdings is .

  • How much funding has Pernix Therapeutical Holdings raised over time?

    Pernix Therapeutical Holdings has raised $216M.

  • Who are Pernix Therapeutical Holdings’s investors?

    Highbridge Capital Management has invested in Pernix Therapeutical Holdings.

  • Who are Pernix Therapeutical Holdings’s competitors?

    Novartis, Cipla, Landsteiner Scientific, Astellas Pharma, and Chiesi Farmaceutici are some of the 42 competitors of Pernix Therapeutical Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process